Cargando…

LRRK2 contributes to monocyte dysregulation in Parkinson’s disease

Detalles Bibliográficos
Autores principales:	Bliederhaeuser, Corinna, Zondler, Lisa, Grozdanov, Veselin, Ruf, Wolfgang P., Brenner, David, Melrose, Heather L., Bauer, Peter, Ludolph, Albert C., Gillardon, Frank, Kassubek, Jan, Weishaupt, Jochen H., Danzer, Karin M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123218/ https://www.ncbi.nlm.nih.gov/pubmed/27884177 http://dx.doi.org/10.1186/s40478-016-0396-2

Ejemplares similares

Inflammatory dysregulation of blood monocytes in Parkinson’s disease patients
por: Grozdanov, Veselin, et al.
Publicado: (2014)

T-cell dysregulation is associated with disease severity in Parkinson’s Disease
por: Bhatia, Divisha, et al.
Publicado: (2021)

α-synuclein interacts with SOD1 and promotes its oligomerization
por: Helferich, Anika M., et al.
Publicado: (2015)

Protein Binding Partners of Dysregulated miRNAs in Parkinson’s Disease Serum
por: Ruf, Wolfgang P., et al.
Publicado: (2021)

Proteasome impairment by α-synuclein
por: Zondler, Lisa, et al.
Publicado: (2017)

Low T-cell reactivity to TDP-43 peptides in ALS
por: Ramachandran, Swetha, et al.
Publicado: (2023)

Age Increases Monocyte Adhesion on Collagen
por: Khalaji, Samira, et al.
Publicado: (2017)

Intracellular Alpha-Synuclein and Immune Cell Function
por: Grozdanov, Veselin, et al.
Publicado: (2020)

Increased NF-L levels in the TDP-43(G298S) ALS mouse model resemble NF-L levels in ALS patients
por: Buck, Eva, et al.
Publicado: (2022)

ALS is imprinted in the chromatin accessibility of blood cells
por: Kühlwein, Julia K., et al.
Publicado: (2023)

The Role of Lipids in the Initiation of α-Synuclein Misfolding
por: Kiechle, Martin, et al.
Publicado: (2020)

Impaired ATF3 signaling involves SNAP25 in SOD1 mutant ALS patients
por: Yazar, Volkan, et al.
Publicado: (2023)

LRRK2 and ubiquitination: implications for kinase inhibitor therapy
por: Melrose, Heather L.
Publicado: (2015)

Longitudinal diffusion tensor magnetic resonance imaging analysis at the cohort level reveals disturbed cortical and callosal microstructure with spared corticospinal tract in the TDP-43(G298S) ALS mouse model
por: Müller, Hans-Peter, et al.
Publicado: (2019)

Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis
por: Freischmidt, Axel, et al.
Publicado: (2013)

Signal Transduction Protein Array Analysis Links LRRK2 to Ste20 Kinases and PKC Zeta That Modulate Neuronal Plasticity
por: Zach, Susanne, et al.
Publicado: (2010)

Gene specific therapies – the next therapeutic milestone in neurology
por: Brenner, David, et al.
Publicado: (2020)

Mitochondrial genome study in blood of maternally inherited ALS cases
por: Brockmann, Sarah J., et al.
Publicado: (2023)

Models for LRRK2-Linked Parkinsonism
por: Li, Tianxia, et al.
Publicado: (2011)

The role of the LRRK2 gene in Parkinsonism
por: Li, Jie-Qiong, et al.
Publicado: (2014)

LRRK2 and Proteostasis in Parkinson’s Disease
por: Pérez-Carrión, María Dolores, et al.
Publicado: (2022)

Targeting LRRK2 in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Dysregulated mRNA Translation in the G2019S LRRK2 and LRRK2 Knock-Out Mouse Brains
por: Kim, Jungwoo Wren, et al.
Publicado: (2021)

Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration
por: Jeong, Ga Ram, et al.
Publicado: (2018)

Stress induced TDP-43 mobility loss independent of stress granules
por: Streit, Lisa, et al.
Publicado: (2022)

In vivo histopathological staging in C9orf72-associated ALS: A tract of interest DTI study
por: Müller, Hans-Peter, et al.
Publicado: (2020)

Haploinsufficiency of TANK-binding kinase 1 prepones age-associated neuroinflammatory changes without causing motor neuron degeneration in aged mice
por: Bruno, Clara, et al.
Publicado: (2020)

Rare variants in LRRK1 and Parkinson's disease
por: Schulte, Eva C., et al.
Publicado: (2013)

The Role of LRRK2 in Neurodegeneration of Parkinson Disease
por: Rui, Qin, et al.
Publicado: (2018)

LRRK2 and the Endolysosomal System in Parkinson’s Disease
por: Erb, Madalynn L., et al.
Publicado: (2020)

LRRK2 at the Crossroad of Aging and Parkinson’s Disease
por: Hur, Eun-Mi, et al.
Publicado: (2021)

Pathological Functions of LRRK2 in Parkinson’s Disease
por: Jeong, Ga Ram, et al.
Publicado: (2020)

Modeling Parkinson’s disease in LRRK2 rodents
por: Domenicale, Chiara, et al.
Publicado: (2023)

Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
por: Maekawa, Tatsunori, et al.
Publicado: (2016)

Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics
por: Bardai, Farah H., et al.
Publicado: (2018)

Pathway-specific dysregulation of striatal excitatory synapses by LRRK2 mutations
por: Chen, Chuyu, et al.
Publicado: (2020)

LRRK2 phosphorylates novel tau epitopes and promotes tauopathy
por: Bailey, Rachel M., et al.
Publicado: (2013)

Detection of endogenous S1292 LRRK2 autophosphorylation in mouse tissue as a readout for kinase activity
por: Kluss, Jillian H., et al.
Publicado: (2018)

Commentary: Effects of ALS-associated TANK binding kinase 1 mutations on protein-protein interactions and kinase activity
por: Freischmidt, Axel, et al.
Publicado: (2020)

An integrated transcriptomics and proteomics analysis reveals functional endocytic dysregulation caused by mutations in LRRK2
por: Connor-Robson, Natalie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bubmk99fa4gi22aqmleh0ec0gi